FDA Approves New Neurostimulator for OSA

Preview text: FDA Approves New Neurostimulator for OSA 96 + Philips DreamStation BiPAP available to…

Sleep ReviewWednesday, Mar 25, 2026 at 5:01 AM EasternHubSpot
Sleep ReviewFDA Approves New Neurostimulator for OSA
Subject
FDA Approves New Neurostimulator for OSA
Preview text
FDA Approves New Neurostimulator for OSA 96 + Philips DreamStation BiPAP available to…
From
news@sleepreviewmag.com
Sent
Wed Mar 25, 2026, 5:01 AM ET
Size
144 KB
Images
17
Links
28, 2 of them buttons
Subject length
40 characters

Against Sleep Review's usual

Sent in the 5 AM hour, which holds 14% of its emails; 20% arrive in the 8 AM hour. The subject is 40 characters; its average is 51.

Report this email

Sent just before and after

More from Sleep Review

All Sleep Review emails

Get the Black Friday insights

We're collecting every Black Friday email from more than 50,000 brands as it lands. Get what we find: who starts first, the biggest discounts, and the subject lines that stand out.

Free. Unsubscribe anytime.